Remove Best Practices Remove Stenosis Remove Tricuspid
article thumbnail

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

DAIC

Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis. The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease.

article thumbnail

CRG Introduces New York Valves: The Structural Heart Summit

DAIC

Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis. The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease.